Home / Octreotide / Canada
CA ATC H01CB02 · updated 2 Nov 2026
Octreotide shortage in Canada
Is there an Octreotide shortage in Canada?
Yes. As of 2 Nov 2026, 3 Octreotide products are reported short in Canada, the first since 17 Jun 2024. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Italy, Spain, Austria, Sweden, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | SANDOSTATIN (1 X 5) | NOVARTIS PHARMACEUTICALS CANADA INC | 17 Jun 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | OCTREOTIDE ACETATE OMEGA (5 x 1mL vial / fiole) | OMEGA LABORATORIES LIMITED | 20 Jul 2026 | 31 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | OCTREOTIDE ACETATE OMEGA (5 x 1mL vial / fiole) | OMEGA LABORATORIES LIMITED | 20 Jul 2026 | 31 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.